An epigenomic landscape of cervical intraepithelial neoplasia and cervical cancer using single-base resolution methylome and hydroxymethylome

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

An epigenomic landscape of cervical intraepithelial neoplasia and cervical cancer using single-base resolution methylome and hydroxymethylome. / Han, Yingxin; Ji, Liyan; Guan, Yanfang; Ma, Mengya; Li, Pansong; Xue, Yinge; Zhang, Yinxin; Huang, Wanqiu; Gong, Yuhua; Jiang, Li; Wang, Xipeng; Xie, Hong; Zhou, Boping; Wang, Jiayin; Wang, Junwen; Han, Jinghua; Deng, Yuliang; Yi, Xin; Gao, Fei; Huang, Jian.

In: Clinical and Translational Medicine, Vol. 11, No. 7, e498, 2021.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Han, Y, Ji, L, Guan, Y, Ma, M, Li, P, Xue, Y, Zhang, Y, Huang, W, Gong, Y, Jiang, L, Wang, X, Xie, H, Zhou, B, Wang, J, Wang, J, Han, J, Deng, Y, Yi, X, Gao, F & Huang, J 2021, 'An epigenomic landscape of cervical intraepithelial neoplasia and cervical cancer using single-base resolution methylome and hydroxymethylome', Clinical and Translational Medicine, vol. 11, no. 7, e498. https://doi.org/10.1002/ctm2.498

APA

Han, Y., Ji, L., Guan, Y., Ma, M., Li, P., Xue, Y., Zhang, Y., Huang, W., Gong, Y., Jiang, L., Wang, X., Xie, H., Zhou, B., Wang, J., Wang, J., Han, J., Deng, Y., Yi, X., Gao, F., & Huang, J. (2021). An epigenomic landscape of cervical intraepithelial neoplasia and cervical cancer using single-base resolution methylome and hydroxymethylome. Clinical and Translational Medicine, 11(7), [e498]. https://doi.org/10.1002/ctm2.498

Vancouver

Han Y, Ji L, Guan Y, Ma M, Li P, Xue Y et al. An epigenomic landscape of cervical intraepithelial neoplasia and cervical cancer using single-base resolution methylome and hydroxymethylome. Clinical and Translational Medicine. 2021;11(7). e498. https://doi.org/10.1002/ctm2.498

Author

Han, Yingxin ; Ji, Liyan ; Guan, Yanfang ; Ma, Mengya ; Li, Pansong ; Xue, Yinge ; Zhang, Yinxin ; Huang, Wanqiu ; Gong, Yuhua ; Jiang, Li ; Wang, Xipeng ; Xie, Hong ; Zhou, Boping ; Wang, Jiayin ; Wang, Junwen ; Han, Jinghua ; Deng, Yuliang ; Yi, Xin ; Gao, Fei ; Huang, Jian. / An epigenomic landscape of cervical intraepithelial neoplasia and cervical cancer using single-base resolution methylome and hydroxymethylome. In: Clinical and Translational Medicine. 2021 ; Vol. 11, No. 7.

Bibtex

@article{56d9bbc54f794554a11d79550e8482b7,
title = "An epigenomic landscape of cervical intraepithelial neoplasia and cervical cancer using single-base resolution methylome and hydroxymethylome",
abstract = "BACKGROUND: Cervical cancer (CC) is the second leading cause of cancer death among women worldwide. Epigenetic regulation of gene expression through DNA methylation and hydroxymethylation plays a pivotal role during tumorigenesis. In this study, to analyze the epigenomic landscape and identify potential biomarkers for CCs, we selected a series of samples from normal to cervical intra-epithelial neoplasia (CINs) to CCs and performed an integrative analysis of whole-genome bisulfite sequencing (WGBS-seq), oxidative WGBS, RNA-seq, and external histone modifications profiling data.RESULTS: In the development and progression of CC, there were genome-wide hypo-methylation and hypo-hydroxymethylation, accompanied by local hyper-methylation and hyper-hydroxymethylation. Hydroxymethylation prefers to distribute in the CpG islands and CpG shores, as displayed a trend of gradual decline from health to CIN2, while a trend of increase from CIN3 to CC. The differentially methylated and hydroxymethylated region-associated genes both enriched in Hippo and other cancer-related signaling pathways that drive cervical carcinogenesis. Furthermore, we identified eight novel differentially methylated/hydroxymethylated-associated genes (DES, MAL, MTIF2, PIP5K1A, RPS6KA6, ANGEL2, MPP, and PAPSS2) significantly correlated with the overall survival of CC. In addition, no any correlation was observed between methylation or hydroxymethylation levels and somatic copy number variations in CINs and CCs.CONCLUSION: Our current study systematically delineates the map of methylome and hydroxymethylome from CINs to CC, and some differentially methylated/hydroxymethylated-associated genes can be used as the potential epigenetic biomarkers in CC prognosis.",
keywords = "Biomarkers, Tumor/genetics, Cervical Intraepithelial Neoplasia/genetics, CpG Islands, DNA Copy Number Variations, DNA Methylation, Epigenomics, Exoribonucleases/genetics, Female, Histones/genetics, Humans, Multienzyme Complexes/genetics, Myelin and Lymphocyte-Associated Proteolipid Proteins/genetics, Signal Transduction, Sulfate Adenylyltransferase/genetics, Survival Rate, Uterine Cervical Neoplasms/genetics",
author = "Yingxin Han and Liyan Ji and Yanfang Guan and Mengya Ma and Pansong Li and Yinge Xue and Yinxin Zhang and Wanqiu Huang and Yuhua Gong and Li Jiang and Xipeng Wang and Hong Xie and Boping Zhou and Jiayin Wang and Junwen Wang and Jinghua Han and Yuliang Deng and Xin Yi and Fei Gao and Jian Huang",
note = "{\textcopyright} 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.",
year = "2021",
doi = "10.1002/ctm2.498",
language = "English",
volume = "11",
journal = "Clinical and Translational Medicine",
issn = "2001-1326",
publisher = "SpringerOpen",
number = "7",

}

RIS

TY - JOUR

T1 - An epigenomic landscape of cervical intraepithelial neoplasia and cervical cancer using single-base resolution methylome and hydroxymethylome

AU - Han, Yingxin

AU - Ji, Liyan

AU - Guan, Yanfang

AU - Ma, Mengya

AU - Li, Pansong

AU - Xue, Yinge

AU - Zhang, Yinxin

AU - Huang, Wanqiu

AU - Gong, Yuhua

AU - Jiang, Li

AU - Wang, Xipeng

AU - Xie, Hong

AU - Zhou, Boping

AU - Wang, Jiayin

AU - Wang, Junwen

AU - Han, Jinghua

AU - Deng, Yuliang

AU - Yi, Xin

AU - Gao, Fei

AU - Huang, Jian

N1 - © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

PY - 2021

Y1 - 2021

N2 - BACKGROUND: Cervical cancer (CC) is the second leading cause of cancer death among women worldwide. Epigenetic regulation of gene expression through DNA methylation and hydroxymethylation plays a pivotal role during tumorigenesis. In this study, to analyze the epigenomic landscape and identify potential biomarkers for CCs, we selected a series of samples from normal to cervical intra-epithelial neoplasia (CINs) to CCs and performed an integrative analysis of whole-genome bisulfite sequencing (WGBS-seq), oxidative WGBS, RNA-seq, and external histone modifications profiling data.RESULTS: In the development and progression of CC, there were genome-wide hypo-methylation and hypo-hydroxymethylation, accompanied by local hyper-methylation and hyper-hydroxymethylation. Hydroxymethylation prefers to distribute in the CpG islands and CpG shores, as displayed a trend of gradual decline from health to CIN2, while a trend of increase from CIN3 to CC. The differentially methylated and hydroxymethylated region-associated genes both enriched in Hippo and other cancer-related signaling pathways that drive cervical carcinogenesis. Furthermore, we identified eight novel differentially methylated/hydroxymethylated-associated genes (DES, MAL, MTIF2, PIP5K1A, RPS6KA6, ANGEL2, MPP, and PAPSS2) significantly correlated with the overall survival of CC. In addition, no any correlation was observed between methylation or hydroxymethylation levels and somatic copy number variations in CINs and CCs.CONCLUSION: Our current study systematically delineates the map of methylome and hydroxymethylome from CINs to CC, and some differentially methylated/hydroxymethylated-associated genes can be used as the potential epigenetic biomarkers in CC prognosis.

AB - BACKGROUND: Cervical cancer (CC) is the second leading cause of cancer death among women worldwide. Epigenetic regulation of gene expression through DNA methylation and hydroxymethylation plays a pivotal role during tumorigenesis. In this study, to analyze the epigenomic landscape and identify potential biomarkers for CCs, we selected a series of samples from normal to cervical intra-epithelial neoplasia (CINs) to CCs and performed an integrative analysis of whole-genome bisulfite sequencing (WGBS-seq), oxidative WGBS, RNA-seq, and external histone modifications profiling data.RESULTS: In the development and progression of CC, there were genome-wide hypo-methylation and hypo-hydroxymethylation, accompanied by local hyper-methylation and hyper-hydroxymethylation. Hydroxymethylation prefers to distribute in the CpG islands and CpG shores, as displayed a trend of gradual decline from health to CIN2, while a trend of increase from CIN3 to CC. The differentially methylated and hydroxymethylated region-associated genes both enriched in Hippo and other cancer-related signaling pathways that drive cervical carcinogenesis. Furthermore, we identified eight novel differentially methylated/hydroxymethylated-associated genes (DES, MAL, MTIF2, PIP5K1A, RPS6KA6, ANGEL2, MPP, and PAPSS2) significantly correlated with the overall survival of CC. In addition, no any correlation was observed between methylation or hydroxymethylation levels and somatic copy number variations in CINs and CCs.CONCLUSION: Our current study systematically delineates the map of methylome and hydroxymethylome from CINs to CC, and some differentially methylated/hydroxymethylated-associated genes can be used as the potential epigenetic biomarkers in CC prognosis.

KW - Biomarkers, Tumor/genetics

KW - Cervical Intraepithelial Neoplasia/genetics

KW - CpG Islands

KW - DNA Copy Number Variations

KW - DNA Methylation

KW - Epigenomics

KW - Exoribonucleases/genetics

KW - Female

KW - Histones/genetics

KW - Humans

KW - Multienzyme Complexes/genetics

KW - Myelin and Lymphocyte-Associated Proteolipid Proteins/genetics

KW - Signal Transduction

KW - Sulfate Adenylyltransferase/genetics

KW - Survival Rate

KW - Uterine Cervical Neoplasms/genetics

U2 - 10.1002/ctm2.498

DO - 10.1002/ctm2.498

M3 - Journal article

C2 - 34323415

VL - 11

JO - Clinical and Translational Medicine

JF - Clinical and Translational Medicine

SN - 2001-1326

IS - 7

M1 - e498

ER -

ID: 299205594